Other than a vague reference to "other molecules in our pipeline" in response to an analyst question earlier this year, I don't believe the company has given any guidance or timeline for a 4th compound.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.